Go back to your search

Healthcare Technology Company - REF:83583


The company has a deep-rooted academic heritage built on 20 years of pioneering research led by the members of the UCL Liver Failure Group. The Scientific founder is a world-renowned hepatologist with decades of experience in advanced liver disease. The company’s platform integrates technical expertise, clinical trial design and execution with its global collaborator network to accelerate development.

Capital raise: £3 million GBP
Headquarters: Herefordshire, England
Type of Entity: Series A company
Use of proceeds: Expansion


  • Carbalive Removes endotoxin, reduces
    bacterial translocation, and improves
    organ function.
  • TLR 4 Reduces sensitivity to endotoxin,
    modulating inflammation.
  • Dialive Removes endotoxin in the blood
    and replaces damaged albumin
    modulating inflammation

Type: Equity
Geography: Europe
Annual revenue: £34m GBP
Min. ticket size: £500K GBP

Price: 3.619.830€

Type Property Included
Status For sale
Franchise Yes
Price 3.619.830€
Revenue No Traslate this String
Cash Flow No Traslate this String

Professional Contact

1- iDealBiz Direct Contact

... Pay Before Worldwide

Professional Contact

1- iDealBiz Direct Contact

... Pay Before Worldwide

    Ask for information

    Advertisement associated with Mediator. You will be contacted by:

    Property information

    Business operations

    Living Accomodations Yes


    Relocatable: Yes
    Owner Financing Available: Yes